(525002, 'HP:0011145', 'Symptomatic seizures', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525003, 'HP:0011145', 'Symptomatic seizures', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525004, 'HP:0011145', 'Symptomatic seizures', 'MP:0005001', 'abnormal clonal deletion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525005, 'HP:0011145', 'Symptomatic seizures', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525006, 'HP:0011145', 'Symptomatic seizures', 'MP:0003777', 'lip inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525007, 'HP:0011145', 'Symptomatic seizures', 'MP:0003489', 'increased channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525008, 'HP:0011145', 'Symptomatic seizures', 'MP:0002193', 'minimal clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525009, 'HP:0011145', 'Symptomatic seizures', 'MP:0011399', 'increased endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525010, 'HP:0011145', 'Symptomatic seizures', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525011, 'HP:0011145', 'Symptomatic seizures', 'MP:0004768', 'abnormal axonal transport', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525012, 'HP:0011145', 'Symptomatic seizures', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525013, 'HP:0011145', 'Symptomatic seizures', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525014, 'HP:0011145', 'Symptomatic seizures', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525015, 'HP:0011145', 'Symptomatic seizures', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525016, 'HP:0011145', 'Symptomatic seizures', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525017, 'HP:0011145', 'Symptomatic seizures', 'MP:0005044', 'sepsis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525018, 'HP:0011145', 'Symptomatic seizures', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525019, 'HP:0011145', 'Symptomatic seizures', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525020, 'HP:0011145', 'Symptomatic seizures', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525021, 'HP:0011145', 'Symptomatic seizures', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525022, 'HP:0011145', 'Symptomatic seizures', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525023, 'HP:0011145', 'Symptomatic seizures', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525024, 'HP:0011145', 'Symptomatic seizures', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525025, 'HP:0011145', 'Symptomatic seizures', 'MP:0003485', 'abnormal channel response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525026, 'HP:0011145', 'Symptomatic seizures', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525027, 'HP:0011145', 'Symptomatic seizures', 'MP:0000947', 'convulsive seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525028, 'HP:0011145', 'Symptomatic seizures', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525029, 'HP:0011145', 'Symptomatic seizures', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525030, 'HP:0011145', 'Symptomatic seizures', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525031, 'HP:0011145', 'Symptomatic seizures', 'MP:0003465', 'increased single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525032, 'HP:0011145', 'Symptomatic seizures', 'MP:0001837', 'defective assembly of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525033, 'HP:0011145', 'Symptomatic seizures', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525034, 'HP:0011145', 'Symptomatic seizures', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525035, 'HP:0011145', 'Symptomatic seizures', 'MP:0004859', 'abnormal synaptic plasticity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525036, 'HP:0011145', 'Symptomatic seizures', 'MP:0013806', 'encephalopathy', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525037, 'HP:0011145', 'Symptomatic seizures', 'MP:0002195', 'psychomotor seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525038, 'HP:0011145', 'Symptomatic seizures', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525039, 'HP:0011145', 'Symptomatic seizures', 'MP:0020424', 'increased kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525040, 'HP:0011145', 'Symptomatic seizures', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525041, 'HP:0011145', 'Symptomatic seizures', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525042, 'HP:0011145', 'Symptomatic seizures', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525043, 'HP:0011145', 'Symptomatic seizures', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525044, 'HP:0011145', 'Symptomatic seizures', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525045, 'HP:0011145', 'Symptomatic seizures', 'MP:0002923', 'increased post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525046, 'HP:0011145', 'Symptomatic seizures', 'MP:0021009', 'abnormal synaptic physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525047, 'HP:0011145', 'Symptomatic seizures', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525048, 'HP:0011145', 'Symptomatic seizures', 'MP:0001917', 'intraventricular hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525049, 'HP:0011145', 'Symptomatic seizures', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525050, 'HP:0011145', 'Symptomatic seizures', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525051, 'HP:0011145', 'Symptomatic seizures', 'MP:0000921', 'demyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525052, 'HP:0011145', 'Symptomatic seizures', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525053, 'HP:0011145', 'Symptomatic seizures', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525054, 'HP:0011145', 'Symptomatic seizures', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525055, 'HP:0011145', 'Symptomatic seizures', 'MP:0012011', 'febrile seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525056, 'HP:0011145', 'Symptomatic seizures', 'MP:0001899', 'absent long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525057, 'HP:0011145', 'Symptomatic seizures', 'MP:0008744', 'abnormal B cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525058, 'HP:0011145', 'Symptomatic seizures', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525059, 'HP:0011145', 'Symptomatic seizures', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525060, 'HP:0011145', 'Symptomatic seizures', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525061, 'HP:0011145', 'Symptomatic seizures', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525062, 'HP:0011145', 'Symptomatic seizures', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525063, 'HP:0011145', 'Symptomatic seizures', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525064, 'HP:0011145', 'Symptomatic seizures', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525065, 'HP:0011145', 'Symptomatic seizures', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525066, 'HP:0011145', 'Symptomatic seizures', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525067, 'HP:0011145', 'Symptomatic seizures', 'MP:0009358', 'environmentally induced seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525068, 'HP:0011145', 'Symptomatic seizures', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525069, 'HP:0011145', 'Symptomatic seizures', 'MP:0003490', 'decreased channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525070, 'HP:0011145', 'Symptomatic seizures', 'MP:0001845', 'abnormal inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525071, 'HP:0011145', 'Symptomatic seizures', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525072, 'HP:0011145', 'Symptomatic seizures', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525073, 'HP:0011145', 'Symptomatic seizures', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525074, 'HP:0011145', 'Symptomatic seizures', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525075, 'HP:0011145', 'Symptomatic seizures', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525076, 'HP:0011145', 'Symptomatic seizures', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525077, 'HP:0011145', 'Symptomatic seizures', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525078, 'HP:0011145', 'Symptomatic seizures', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525079, 'HP:0011145', 'Symptomatic seizures', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525080, 'HP:0011145', 'Symptomatic seizures', 'MP:0031221', 'abnormal CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525081, 'HP:0011145', 'Symptomatic seizures', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525082, 'HP:0011145', 'Symptomatic seizures', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525083, 'HP:0011145', 'Symptomatic seizures', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525084, 'HP:0011145', 'Symptomatic seizures', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525085, 'HP:0011145', 'Symptomatic seizures', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525086, 'HP:0011145', 'Symptomatic seizures', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525087, 'HP:0011145', 'Symptomatic seizures', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525088, 'HP:0011145', 'Symptomatic seizures', 'MP:0003990', 'decreased neurotransmitter release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525089, 'HP:0011145', 'Symptomatic seizures', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525090, 'HP:0011145', 'Symptomatic seizures', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525091, 'HP:0011145', 'Symptomatic seizures', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525092, 'HP:0011145', 'Symptomatic seizures', 'MP:0003635', 'abnormal synaptic transmission', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525093, 'HP:0011145', 'Symptomatic seizures', 'MP:0031170', 'abnormal vasculature physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525094, 'HP:0011145', 'Symptomatic seizures', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525095, 'HP:0011145', 'Symptomatic seizures', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525096, 'HP:0011145', 'Symptomatic seizures', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525097, 'HP:0011145', 'Symptomatic seizures', 'MP:0004994', 'abnormal brain wave pattern', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525098, 'HP:0011145', 'Symptomatic seizures', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525099, 'HP:0011145', 'Symptomatic seizures', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525100, 'HP:0011145', 'Symptomatic seizures', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525101, 'HP:0011145', 'Symptomatic seizures', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525102, 'HP:0011145', 'Symptomatic seizures', 'MP:0004811', 'abnormal neuron physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525103, 'HP:0011145', 'Symptomatic seizures', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525104, 'HP:0011145', 'Symptomatic seizures', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525105, 'HP:0011145', 'Symptomatic seizures', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525106, 'HP:0011145', 'Symptomatic seizures', 'MP:0005043', 'defective assembly of class II molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525107, 'HP:0011145', 'Symptomatic seizures', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525108, 'HP:0011145', 'Symptomatic seizures', 'MP:0006114', 'cardiac murmur', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525109, 'HP:0011145', 'Symptomatic seizures', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525110, 'HP:0011145', 'Symptomatic seizures', 'MP:0021026', 'decreased cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525111, 'HP:0011145', 'Symptomatic seizures', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525112, 'HP:0011145', 'Symptomatic seizures', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525113, 'HP:0011145', 'Symptomatic seizures', 'MP:0002420', 'abnormal adaptive immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525114, 'HP:0011145', 'Symptomatic seizures', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525115, 'HP:0011145', 'Symptomatic seizures', 'MP:0003762', 'abnormal immune organ physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525116, 'HP:0011145', 'Symptomatic seizures', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525117, 'HP:0011145', 'Symptomatic seizures', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525118, 'HP:0011145', 'Symptomatic seizures', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525119, 'HP:0011145', 'Symptomatic seizures', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525120, 'HP:0011145', 'Symptomatic seizures', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525121, 'HP:0011145', 'Symptomatic seizures', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525122, 'HP:0011145', 'Symptomatic seizures', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525123, 'HP:0011145', 'Symptomatic seizures', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525124, 'HP:0011145', 'Symptomatic seizures', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525125, 'HP:0011145', 'Symptomatic seizures', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525126, 'HP:0011145', 'Symptomatic seizures', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525127, 'HP:0011145', 'Symptomatic seizures', 'MP:0020002', 'increased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525128, 'HP:0011145', 'Symptomatic seizures', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525129, 'HP:0011145', 'Symptomatic seizures', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525130, 'HP:0011145', 'Symptomatic seizures', 'MP:0006053', 'hypothalamus hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525131, 'HP:0011145', 'Symptomatic seizures', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525132, 'HP:0011145', 'Symptomatic seizures', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525133, 'HP:0011145', 'Symptomatic seizures', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525134, 'HP:0011145', 'Symptomatic seizures', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525135, 'HP:0011145', 'Symptomatic seizures', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525136, 'HP:0011145', 'Symptomatic seizures', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525137, 'HP:0011145', 'Symptomatic seizures', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525138, 'HP:0011145', 'Symptomatic seizures', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525139, 'HP:0011145', 'Symptomatic seizures', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525140, 'HP:0011145', 'Symptomatic seizures', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525141, 'HP:0011145', 'Symptomatic seizures', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525142, 'HP:0011145', 'Symptomatic seizures', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525143, 'HP:0011145', 'Symptomatic seizures', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525144, 'HP:0011145', 'Symptomatic seizures', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525145, 'HP:0011145', 'Symptomatic seizures', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525146, 'HP:0011145', 'Symptomatic seizures', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525147, 'HP:0011145', 'Symptomatic seizures', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525148, 'HP:0011145', 'Symptomatic seizures', 'MP:0013971', 'blood in lymph vessels', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525149, 'HP:0011145', 'Symptomatic seizures', 'MP:0031109', 'subarachnoid hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525150, 'HP:0011145', 'Symptomatic seizures', 'MP:0009141', 'increased prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525151, 'HP:0011145', 'Symptomatic seizures', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525152, 'HP:0011145', 'Symptomatic seizures', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525153, 'HP:0011145', 'Symptomatic seizures', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525154, 'HP:0011145', 'Symptomatic seizures', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525155, 'HP:0011145', 'Symptomatic seizures', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525156, 'HP:0011145', 'Symptomatic seizures', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525157, 'HP:0011145', 'Symptomatic seizures', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525158, 'HP:0011145', 'Symptomatic seizures', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525159, 'HP:0011145', 'Symptomatic seizures', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525160, 'HP:0011145', 'Symptomatic seizures', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525161, 'HP:0011145', 'Symptomatic seizures', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525162, 'HP:0011145', 'Symptomatic seizures', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525163, 'HP:0011145', 'Symptomatic seizures', 'MP:0008555', 'abnormal interferon secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525164, 'HP:0011145', 'Symptomatic seizures', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525165, 'HP:0011145', 'Symptomatic seizures', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525166, 'HP:0011145', 'Symptomatic seizures', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525167, 'HP:0011145', 'Symptomatic seizures', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525168, 'HP:0011145', 'Symptomatic seizures', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525169, 'HP:0011145', 'Symptomatic seizures', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525170, 'HP:0011145', 'Symptomatic seizures', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525171, 'HP:0011145', 'Symptomatic seizures', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525172, 'HP:0011145', 'Symptomatic seizures', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525173, 'HP:0011145', 'Symptomatic seizures', 'MP:0003009', 'abnormal cytokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525174, 'HP:0011145', 'Symptomatic seizures', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525175, 'HP:0011145', 'Symptomatic seizures', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525176, 'HP:0011145', 'Symptomatic seizures', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525177, 'HP:0011145', 'Symptomatic seizures', 'MP:0012504', 'increased forebrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525178, 'HP:0011145', 'Symptomatic seizures', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525179, 'HP:0011145', 'Symptomatic seizures', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525180, 'HP:0011145', 'Symptomatic seizures', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525181, 'HP:0011145', 'Symptomatic seizures', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525182, 'HP:0011145', 'Symptomatic seizures', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525183, 'HP:0011145', 'Symptomatic seizures', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525184, 'HP:0011145', 'Symptomatic seizures', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525185, 'HP:0011145', 'Symptomatic seizures', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525186, 'HP:0011145', 'Symptomatic seizures', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525187, 'HP:0011145', 'Symptomatic seizures', 'MP:0003823', 'increased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525188, 'HP:0011145', 'Symptomatic seizures', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525189, 'HP:0011145', 'Symptomatic seizures', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525190, 'HP:0011145', 'Symptomatic seizures', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525191, 'HP:0011145', 'Symptomatic seizures', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525192, 'HP:0011145', 'Symptomatic seizures', 'MP:0003471', 'abnormal summary potential threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525193, 'HP:0011145', 'Symptomatic seizures', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525194, 'HP:0011145', 'Symptomatic seizures', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525195, 'HP:0011145', 'Symptomatic seizures', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525196, 'HP:0011145', 'Symptomatic seizures', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525197, 'HP:0011145', 'Symptomatic seizures', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525198, 'HP:0011145', 'Symptomatic seizures', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525199, 'HP:0011145', 'Symptomatic seizures', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525200, 'HP:0011145', 'Symptomatic seizures', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525201, 'HP:0011145', 'Symptomatic seizures', 'MP:0003997', 'tonic-clonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525202, 'HP:0011145', 'Symptomatic seizures', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525203, 'HP:0011145', 'Symptomatic seizures', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525204, 'HP:0011145', 'Symptomatic seizures', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525205, 'HP:0011145', 'Symptomatic seizures', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525206, 'HP:0011145', 'Symptomatic seizures', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525207, 'HP:0011145', 'Symptomatic seizures', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525208, 'HP:0011145', 'Symptomatic seizures', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525209, 'HP:0011145', 'Symptomatic seizures', 'MP:0021016', 'decreased tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525210, 'HP:0011145', 'Symptomatic seizures', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525211, 'HP:0011145', 'Symptomatic seizures', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525212, 'HP:0011145', 'Symptomatic seizures', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525213, 'HP:0011145', 'Symptomatic seizures', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525214, 'HP:0011145', 'Symptomatic seizures', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525215, 'HP:0011145', 'Symptomatic seizures', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525216, 'HP:0011145', 'Symptomatic seizures', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525217, 'HP:0011145', 'Symptomatic seizures', 'MP:0003472', 'increased summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525218, 'HP:0011145', 'Symptomatic seizures', 'MP:0003477', 'abnormal nerve fiber response', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525219, 'HP:0011145', 'Symptomatic seizures', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525220, 'HP:0011145', 'Symptomatic seizures', 'MP:0008776', 'increased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525221, 'HP:0011145', 'Symptomatic seizures', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525222, 'HP:0011145', 'Symptomatic seizures', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525223, 'HP:0011145', 'Symptomatic seizures', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525224, 'HP:0011145', 'Symptomatic seizures', 'MP:0001473', 'reduced long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525225, 'HP:0011145', 'Symptomatic seizures', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525226, 'HP:0011145', 'Symptomatic seizures', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525227, 'HP:0011145', 'Symptomatic seizures', 'MP:0004835', 'abnormal miniature endplate potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525228, 'HP:0011145', 'Symptomatic seizures', 'MP:0005623', 'abnormal meninges morphology', 0.4074074074074074, 4.0017449178869, 1.2768478852635776, 'UPHENO:0004523', 'abnormal nervous system'),
(525229, 'HP:0011145', 'Symptomatic seizures', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525230, 'HP:0011145', 'Symptomatic seizures', 'MP:0013182', 'increased spinal cord apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525231, 'HP:0011145', 'Symptomatic seizures', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525232, 'HP:0011145', 'Symptomatic seizures', 'MP:0005025', 'abnormal response to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525233, 'HP:0011145', 'Symptomatic seizures', 'MP:0011068', 'abnormal ependyma motile cilium physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525234, 'HP:0011145', 'Symptomatic seizures', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525235, 'HP:0011145', 'Symptomatic seizures', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525236, 'HP:0011145', 'Symptomatic seizures', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525237, 'HP:0011145', 'Symptomatic seizures', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525238, 'HP:0011145', 'Symptomatic seizures', 'MP:0003470', 'abnormal summary potential', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525239, 'HP:0011145', 'Symptomatic seizures', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525240, 'HP:0011145', 'Symptomatic seizures', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525241, 'HP:0011145', 'Symptomatic seizures', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525242, 'HP:0011145', 'Symptomatic seizures', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525243, 'HP:0011145', 'Symptomatic seizures', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525244, 'HP:0011145', 'Symptomatic seizures', 'MP:0001915', 'intracranial hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525245, 'HP:0011145', 'Symptomatic seizures', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525246, 'HP:0011145', 'Symptomatic seizures', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525247, 'HP:0011145', 'Symptomatic seizures', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525248, 'HP:0011145', 'Symptomatic seizures', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525249, 'HP:0011145', 'Symptomatic seizures', 'MP:0001900', 'impaired synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525250, 'HP:0011145', 'Symptomatic seizures', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525251, 'HP:0011145', 'Symptomatic seizures', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525252, 'HP:0011145', 'Symptomatic seizures', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525253, 'HP:0011145', 'Symptomatic seizures', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525254, 'HP:0011145', 'Symptomatic seizures', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525255, 'HP:0011145', 'Symptomatic seizures', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525256, 'HP:0011145', 'Symptomatic seizures', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525257, 'HP:0011145', 'Symptomatic seizures', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525258, 'HP:0011145', 'Symptomatic seizures', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525259, 'HP:0011145', 'Symptomatic seizures', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525260, 'HP:0011145', 'Symptomatic seizures', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525261, 'HP:0011145', 'Symptomatic seizures', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525262, 'HP:0011145', 'Symptomatic seizures', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525263, 'HP:0011145', 'Symptomatic seizures', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525264, 'HP:0011145', 'Symptomatic seizures', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525265, 'HP:0011145', 'Symptomatic seizures', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525266, 'HP:0011145', 'Symptomatic seizures', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525267, 'HP:0011145', 'Symptomatic seizures', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525268, 'HP:0011145', 'Symptomatic seizures', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525269, 'HP:0011145', 'Symptomatic seizures', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525270, 'HP:0011145', 'Symptomatic seizures', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525271, 'HP:0011145', 'Symptomatic seizures', 'MP:0002916', 'increased synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525272, 'HP:0011145', 'Symptomatic seizures', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525273, 'HP:0011145', 'Symptomatic seizures', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525274, 'HP:0011145', 'Symptomatic seizures', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525275, 'HP:0011145', 'Symptomatic seizures', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525276, 'HP:0011145', 'Symptomatic seizures', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525277, 'HP:0011145', 'Symptomatic seizures', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525278, 'HP:0011145', 'Symptomatic seizures', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525279, 'HP:0011145', 'Symptomatic seizures', 'MP:0006052', 'cerebellum hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525280, 'HP:0011145', 'Symptomatic seizures', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525281, 'HP:0011145', 'Symptomatic seizures', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525282, 'HP:0011145', 'Symptomatic seizures', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525283, 'HP:0011145', 'Symptomatic seizures', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525284, 'HP:0011145', 'Symptomatic seizures', 'MP:0030132', 'periodontium inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525285, 'HP:0011145', 'Symptomatic seizures', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525286, 'HP:0011145', 'Symptomatic seizures', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525287, 'HP:0011145', 'Symptomatic seizures', 'MP:0001898', 'abnormal long-term depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525288, 'HP:0011145', 'Symptomatic seizures', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525289, 'HP:0011145', 'Symptomatic seizures', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525290, 'HP:0011145', 'Symptomatic seizures', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525291, 'HP:0011145', 'Symptomatic seizures', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525292, 'HP:0011145', 'Symptomatic seizures', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525293, 'HP:0011145', 'Symptomatic seizures', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525294, 'HP:0011145', 'Symptomatic seizures', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525295, 'HP:0011145', 'Symptomatic seizures', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525296, 'HP:0011145', 'Symptomatic seizures', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525297, 'HP:0011145', 'Symptomatic seizures', 'MP:0031110', 'meningitis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525298, 'HP:0011145', 'Symptomatic seizures', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525299, 'HP:0011145', 'Symptomatic seizures', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525300, 'HP:0011145', 'Symptomatic seizures', 'MP:0014255', 'increased paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525301, 'HP:0011145', 'Symptomatic seizures', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525302, 'HP:0011145', 'Symptomatic seizures', 'MP:0000243', 'myoclonus', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525303, 'HP:0011145', 'Symptomatic seizures', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525304, 'HP:0011145', 'Symptomatic seizures', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525305, 'HP:0011145', 'Symptomatic seizures', 'MP:0002915', 'abnormal synaptic depression', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525306, 'HP:0011145', 'Symptomatic seizures', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525307, 'HP:0011145', 'Symptomatic seizures', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525308, 'HP:0011145', 'Symptomatic seizures', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525309, 'HP:0011145', 'Symptomatic seizures', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525310, 'HP:0011145', 'Symptomatic seizures', 'MP:0003475', 'increased summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525311, 'HP:0011145', 'Symptomatic seizures', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525312, 'HP:0011145', 'Symptomatic seizures', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525313, 'HP:0011145', 'Symptomatic seizures', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525314, 'HP:0011145', 'Symptomatic seizures', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525315, 'HP:0011145', 'Symptomatic seizures', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525316, 'HP:0011145', 'Symptomatic seizures', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525317, 'HP:0011145', 'Symptomatic seizures', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525318, 'HP:0011145', 'Symptomatic seizures', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525319, 'HP:0011145', 'Symptomatic seizures', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525320, 'HP:0011145', 'Symptomatic seizures', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525321, 'HP:0011145', 'Symptomatic seizures', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525322, 'HP:0011145', 'Symptomatic seizures', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525323, 'HP:0011145', 'Symptomatic seizures', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525324, 'HP:0011145', 'Symptomatic seizures', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525325, 'HP:0011145', 'Symptomatic seizures', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525326, 'HP:0011145', 'Symptomatic seizures', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525327, 'HP:0011145', 'Symptomatic seizures', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525328, 'HP:0011145', 'Symptomatic seizures', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525329, 'HP:0011145', 'Symptomatic seizures', 'MP:0008748', 'abnormal central T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525330, 'HP:0011145', 'Symptomatic seizures', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525331, 'HP:0011145', 'Symptomatic seizures', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525332, 'HP:0011145', 'Symptomatic seizures', 'MP:0021025', 'increased cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525333, 'HP:0011145', 'Symptomatic seizures', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525334, 'HP:0011145', 'Symptomatic seizures', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525335, 'HP:0011145', 'Symptomatic seizures', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525336, 'HP:0011145', 'Symptomatic seizures', 'MP:0001496', 'audiogenic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525337, 'HP:0011145', 'Symptomatic seizures', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525338, 'HP:0011145', 'Symptomatic seizures', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525339, 'HP:0011145', 'Symptomatic seizures', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525340, 'HP:0011145', 'Symptomatic seizures', 'MP:0001790', 'abnormal immune system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525341, 'HP:0011145', 'Symptomatic seizures', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525342, 'HP:0011145', 'Symptomatic seizures', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525343, 'HP:0011145', 'Symptomatic seizures', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525344, 'HP:0011145', 'Symptomatic seizures', 'MP:0002578', 'impaired ability to fire action potentials', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525345, 'HP:0011145', 'Symptomatic seizures', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525346, 'HP:0011145', 'Symptomatic seizures', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525347, 'HP:0011145', 'Symptomatic seizures', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525348, 'HP:0011145', 'Symptomatic seizures', 'MP:0001800', 'abnormal humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525349, 'HP:0011145', 'Symptomatic seizures', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525350, 'HP:0011145', 'Symptomatic seizures', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525351, 'HP:0011145', 'Symptomatic seizures', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525352, 'HP:0011145', 'Symptomatic seizures', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525353, 'HP:0011145', 'Symptomatic seizures', 'MP:0002723', 'abnormal immune serum protein physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525354, 'HP:0011145', 'Symptomatic seizures', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525355, 'HP:0011145', 'Symptomatic seizures', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525356, 'HP:0011145', 'Symptomatic seizures', 'MP:0003880', 'abnormal central pattern generator function', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525357, 'HP:0011145', 'Symptomatic seizures', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525358, 'HP:0011145', 'Symptomatic seizures', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525359, 'HP:0011145', 'Symptomatic seizures', 'MP:0002499', 'chronic inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525360, 'HP:0011145', 'Symptomatic seizures', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525361, 'HP:0011145', 'Symptomatic seizures', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525362, 'HP:0011145', 'Symptomatic seizures', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525363, 'HP:0011145', 'Symptomatic seizures', 'MP:0005671', 'abnormal response to transplant', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525364, 'HP:0011145', 'Symptomatic seizures', 'MP:0008568', 'abnormal interleukin secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525365, 'HP:0011145', 'Symptomatic seizures', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525366, 'HP:0011145', 'Symptomatic seizures', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525367, 'HP:0011145', 'Symptomatic seizures', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525368, 'HP:0011145', 'Symptomatic seizures', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525369, 'HP:0011145', 'Symptomatic seizures', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525370, 'HP:0011145', 'Symptomatic seizures', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525371, 'HP:0011145', 'Symptomatic seizures', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525372, 'HP:0011145', 'Symptomatic seizures', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525373, 'HP:0011145', 'Symptomatic seizures', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525374, 'HP:0011145', 'Symptomatic seizures', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525375, 'HP:0011145', 'Symptomatic seizures', 'MP:0002634', 'abnormal sensorimotor gating', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525376, 'HP:0011145', 'Symptomatic seizures', 'MP:0002914', 'abnormal endplate potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525377, 'HP:0011145', 'Symptomatic seizures', 'MP:0012565', 'perivasculitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525378, 'HP:0011145', 'Symptomatic seizures', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525379, 'HP:0011145', 'Symptomatic seizures', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525380, 'HP:0011145', 'Symptomatic seizures', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525381, 'HP:0011145', 'Symptomatic seizures', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525382, 'HP:0011145', 'Symptomatic seizures', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525383, 'HP:0011145', 'Symptomatic seizures', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525384, 'HP:0011145', 'Symptomatic seizures', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525385, 'HP:0011145', 'Symptomatic seizures', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525386, 'HP:0011145', 'Symptomatic seizures', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525387, 'HP:0011145', 'Symptomatic seizures', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525388, 'HP:0011145', 'Symptomatic seizures', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525389, 'HP:0011145', 'Symptomatic seizures', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525390, 'HP:0011145', 'Symptomatic seizures', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525391, 'HP:0011145', 'Symptomatic seizures', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525392, 'HP:0011145', 'Symptomatic seizures', 'MP:0003474', 'abnormal summary potential intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525393, 'HP:0011145', 'Symptomatic seizures', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525394, 'HP:0011145', 'Symptomatic seizures', 'MP:0000948', 'nonconvulsive seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525395, 'HP:0011145', 'Symptomatic seizures', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525396, 'HP:0011145', 'Symptomatic seizures', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525397, 'HP:0011145', 'Symptomatic seizures', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525398, 'HP:0011145', 'Symptomatic seizures', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525399, 'HP:0011145', 'Symptomatic seizures', 'MP:0003463', 'abnormal single cell response', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525400, 'HP:0011145', 'Symptomatic seizures', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525401, 'HP:0011145', 'Symptomatic seizures', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525402, 'HP:0011145', 'Symptomatic seizures', 'MP:0014253', 'decreased paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525403, 'HP:0011145', 'Symptomatic seizures', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525404, 'HP:0011145', 'Symptomatic seizures', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525405, 'HP:0011145', 'Symptomatic seizures', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525406, 'HP:0011145', 'Symptomatic seizures', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525407, 'HP:0011145', 'Symptomatic seizures', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525408, 'HP:0011145', 'Symptomatic seizures', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525409, 'HP:0011145', 'Symptomatic seizures', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525410, 'HP:0011145', 'Symptomatic seizures', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525411, 'HP:0011145', 'Symptomatic seizures', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525412, 'HP:0011145', 'Symptomatic seizures', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525413, 'HP:0011145', 'Symptomatic seizures', 'MP:0003476', 'decreased summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525414, 'HP:0011145', 'Symptomatic seizures', 'MP:0013208', 'abnormal cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525415, 'HP:0011145', 'Symptomatic seizures', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525416, 'HP:0011145', 'Symptomatic seizures', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525417, 'HP:0011145', 'Symptomatic seizures', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525418, 'HP:0011145', 'Symptomatic seizures', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525419, 'HP:0011145', 'Symptomatic seizures', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525420, 'HP:0011145', 'Symptomatic seizures', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525421, 'HP:0011145', 'Symptomatic seizures', 'MP:0014254', 'increased paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525422, 'HP:0011145', 'Symptomatic seizures', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525423, 'HP:0011145', 'Symptomatic seizures', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525424, 'HP:0011145', 'Symptomatic seizures', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525425, 'HP:0011145', 'Symptomatic seizures', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525426, 'HP:0011145', 'Symptomatic seizures', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525427, 'HP:0011145', 'Symptomatic seizures', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525428, 'HP:0011145', 'Symptomatic seizures', 'MP:0009967', 'abnormal neuron proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525429, 'HP:0011145', 'Symptomatic seizures', 'MP:0001909', 'reduced NMDA receptor mediated synaptic activity in barrel cortex', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525430, 'HP:0011145', 'Symptomatic seizures', 'MP:0001846', 'increased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525431, 'HP:0011145', 'Symptomatic seizures', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525432, 'HP:0011145', 'Symptomatic seizures', 'MP:0003468', 'increased single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525433, 'HP:0011145', 'Symptomatic seizures', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525434, 'HP:0011145', 'Symptomatic seizures', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525435, 'HP:0011145', 'Symptomatic seizures', 'MP:0003488', 'decreased channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525436, 'HP:0011145', 'Symptomatic seizures', 'MP:0010050', 'hypermyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525437, 'HP:0011145', 'Symptomatic seizures', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525438, 'HP:0011145', 'Symptomatic seizures', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525439, 'HP:0011145', 'Symptomatic seizures', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525440, 'HP:0011145', 'Symptomatic seizures', 'MP:0003412', 'abnormal afterhyperpolarization', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525441, 'HP:0011145', 'Symptomatic seizures', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525442, 'HP:0011145', 'Symptomatic seizures', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525443, 'HP:0011145', 'Symptomatic seizures', 'MP:0009062', 'impaired lectin complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525444, 'HP:0011145', 'Symptomatic seizures', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525445, 'HP:0011145', 'Symptomatic seizures', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525446, 'HP:0011145', 'Symptomatic seizures', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525447, 'HP:0011145', 'Symptomatic seizures', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525448, 'HP:0011145', 'Symptomatic seizures', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525449, 'HP:0011145', 'Symptomatic seizures', 'MP:0006324', 'abnormal cochlear nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525450, 'HP:0011145', 'Symptomatic seizures', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525451, 'HP:0011145', 'Symptomatic seizures', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525452, 'HP:0011145', 'Symptomatic seizures', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525453, 'HP:0011145', 'Symptomatic seizures', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525454, 'HP:0011145', 'Symptomatic seizures', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525455, 'HP:0011145', 'Symptomatic seizures', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525456, 'HP:0011145', 'Symptomatic seizures', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525457, 'HP:0011145', 'Symptomatic seizures', 'MP:0012554', 'increased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525458, 'HP:0011145', 'Symptomatic seizures', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525459, 'HP:0011145', 'Symptomatic seizures', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525460, 'HP:0011145', 'Symptomatic seizures', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525461, 'HP:0011145', 'Symptomatic seizures', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525462, 'HP:0011145', 'Symptomatic seizures', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525463, 'HP:0011145', 'Symptomatic seizures', 'MP:0001835', 'abnormal antigen presentation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525464, 'HP:0011145', 'Symptomatic seizures', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525465, 'HP:0011145', 'Symptomatic seizures', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525466, 'HP:0011145', 'Symptomatic seizures', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525467, 'HP:0011145', 'Symptomatic seizures', 'MP:0005167', 'abnormal blood-brain barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525468, 'HP:0011145', 'Symptomatic seizures', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525469, 'HP:0011145', 'Symptomatic seizures', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525470, 'HP:0011145', 'Symptomatic seizures', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525471, 'HP:0011145', 'Symptomatic seizures', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525472, 'HP:0011145', 'Symptomatic seizures', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525473, 'HP:0011145', 'Symptomatic seizures', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525474, 'HP:0011145', 'Symptomatic seizures', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525475, 'HP:0011145', 'Symptomatic seizures', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525476, 'HP:0011145', 'Symptomatic seizures', 'MP:0001475', 'reduced long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525477, 'HP:0011145', 'Symptomatic seizures', 'MP:0003889', 'enhanced sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525478, 'HP:0011145', 'Symptomatic seizures', 'MP:0003480', 'increased nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525479, 'HP:0011145', 'Symptomatic seizures', 'MP:0004415', 'abnormal cochlear nerve compound action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525480, 'HP:0011145', 'Symptomatic seizures', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525481, 'HP:0011145', 'Symptomatic seizures', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525482, 'HP:0011145', 'Symptomatic seizures', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525483, 'HP:0011145', 'Symptomatic seizures', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525484, 'HP:0011145', 'Symptomatic seizures', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525485, 'HP:0011145', 'Symptomatic seizures', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525486, 'HP:0011145', 'Symptomatic seizures', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525487, 'HP:0011145', 'Symptomatic seizures', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525488, 'HP:0011145', 'Symptomatic seizures', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525489, 'HP:0011145', 'Symptomatic seizures', 'MP:0003690', 'abnormal glial cell physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525490, 'HP:0011145', 'Symptomatic seizures', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525491, 'HP:0011145', 'Symptomatic seizures', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525492, 'HP:0011145', 'Symptomatic seizures', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525493, 'HP:0011145', 'Symptomatic seizures', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525494, 'HP:0011145', 'Symptomatic seizures', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525495, 'HP:0011145', 'Symptomatic seizures', 'MP:0020154', 'impaired humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525496, 'HP:0011145', 'Symptomatic seizures', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525497, 'HP:0011145', 'Symptomatic seizures', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525498, 'HP:0011145', 'Symptomatic seizures', 'MP:0005403', 'abnormal nerve conduction', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525499, 'HP:0011145', 'Symptomatic seizures', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525500, 'HP:0011145', 'Symptomatic seizures', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525501, 'HP:0011145', 'Symptomatic seizures', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525502, 'HP:0011145', 'Symptomatic seizures', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525503, 'HP:0011145', 'Symptomatic seizures', 'MP:0030153', 'dental pulp inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525504, 'HP:0011145', 'Symptomatic seizures', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525505, 'HP:0011145', 'Symptomatic seizures', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525506, 'HP:0011145', 'Symptomatic seizures', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525507, 'HP:0011145', 'Symptomatic seizures', 'MP:0002409', 'decreased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525508, 'HP:0011145', 'Symptomatic seizures', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525509, 'HP:0011145', 'Symptomatic seizures', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525510, 'HP:0011145', 'Symptomatic seizures', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525511, 'HP:0011145', 'Symptomatic seizures', 'MP:0002498', 'abnormal acute inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525512, 'HP:0011145', 'Symptomatic seizures', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525513, 'HP:0011145', 'Symptomatic seizures', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525514, 'HP:0011145', 'Symptomatic seizures', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525515, 'HP:0011145', 'Symptomatic seizures', 'MP:0003464', 'abnormal single cell response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525516, 'HP:0011145', 'Symptomatic seizures', 'MP:0003088', 'abnormal prepulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525517, 'HP:0011145', 'Symptomatic seizures', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525518, 'HP:0011145', 'Symptomatic seizures', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525519, 'HP:0011145', 'Symptomatic seizures', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525520, 'HP:0011145', 'Symptomatic seizures', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525521, 'HP:0011145', 'Symptomatic seizures', 'MP:0001499', 'abnormal kindling response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525522, 'HP:0011145', 'Symptomatic seizures', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525523, 'HP:0011145', 'Symptomatic seizures', 'MP:0008921', 'increased neurotransmitter release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525524, 'HP:0011145', 'Symptomatic seizures', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525525, 'HP:0011145', 'Symptomatic seizures', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525526, 'HP:0011145', 'Symptomatic seizures', 'MP:0004513', 'avnosmia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525527, 'HP:0011145', 'Symptomatic seizures', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525528, 'HP:0011145', 'Symptomatic seizures', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525529, 'HP:0011145', 'Symptomatic seizures', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525530, 'HP:0011145', 'Symptomatic seizures', 'MP:0011919', 'abnormal R wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525531, 'HP:0011145', 'Symptomatic seizures', 'MP:0002471', 'abnormal complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525532, 'HP:0011145', 'Symptomatic seizures', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525533, 'HP:0011145', 'Symptomatic seizures', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525534, 'HP:0011145', 'Symptomatic seizures', 'MP:0014179', 'abnormal blood-retina barrier function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525535, 'HP:0011145', 'Symptomatic seizures', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525536, 'HP:0011145', 'Symptomatic seizures', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525537, 'HP:0011145', 'Symptomatic seizures', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525538, 'HP:0011145', 'Symptomatic seizures', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525539, 'HP:0011145', 'Symptomatic seizures', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525540, 'HP:0011145', 'Symptomatic seizures', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525541, 'HP:0011145', 'Symptomatic seizures', 'MP:0020001', 'decreased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525542, 'HP:0011145', 'Symptomatic seizures', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525543, 'HP:0011145', 'Symptomatic seizures', 'MP:0011994', 'increased nerve conduction velocity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525544, 'HP:0011145', 'Symptomatic seizures', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525545, 'HP:0011145', 'Symptomatic seizures', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525546, 'HP:0011145', 'Symptomatic seizures', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525547, 'HP:0011145', 'Symptomatic seizures', 'MP:0005000', 'abnormal immune tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525548, 'HP:0011145', 'Symptomatic seizures', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525549, 'HP:0011145', 'Symptomatic seizures', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525550, 'HP:0011145', 'Symptomatic seizures', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525551, 'HP:0011145', 'Symptomatic seizures', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525552, 'HP:0011145', 'Symptomatic seizures', 'MP:0003217', 'increased spike-wave discharge type I', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525553, 'HP:0011145', 'Symptomatic seizures', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525554, 'HP:0011145', 'Symptomatic seizures', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525555, 'HP:0011145', 'Symptomatic seizures', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525556, 'HP:0011145', 'Symptomatic seizures', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525557, 'HP:0011145', 'Symptomatic seizures', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525558, 'HP:0011145', 'Symptomatic seizures', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525559, 'HP:0011145', 'Symptomatic seizures', 'MP:0005402', 'abnormal action potential', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525560, 'HP:0011145', 'Symptomatic seizures', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525561, 'HP:0011145', 'Symptomatic seizures', 'MP:0003486', 'abnormal channel response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525562, 'HP:0011145', 'Symptomatic seizures', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525563, 'HP:0011145', 'Symptomatic seizures', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525564, 'HP:0011145', 'Symptomatic seizures', 'MP:0014178', 'increased brain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525565, 'HP:0011145', 'Symptomatic seizures', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525566, 'HP:0011145', 'Symptomatic seizures', 'MP:0003008', 'enhanced long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525567, 'HP:0011145', 'Symptomatic seizures', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525568, 'HP:0011145', 'Symptomatic seizures', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525569, 'HP:0011145', 'Symptomatic seizures', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525570, 'HP:0011145', 'Symptomatic seizures', 'MP:0021084', 'decreased cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525571, 'HP:0011145', 'Symptomatic seizures', 'MP:0006080', 'brain ischemia', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525572, 'HP:0011145', 'Symptomatic seizures', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525573, 'HP:0011145', 'Symptomatic seizures', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525574, 'HP:0011145', 'Symptomatic seizures', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525575, 'HP:0011145', 'Symptomatic seizures', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525576, 'HP:0011145', 'Symptomatic seizures', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525577, 'HP:0011145', 'Symptomatic seizures', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525578, 'HP:0011145', 'Symptomatic seizures', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525579, 'HP:0011145', 'Symptomatic seizures', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525580, 'HP:0011145', 'Symptomatic seizures', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525581, 'HP:0011145', 'Symptomatic seizures', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525582, 'HP:0011145', 'Symptomatic seizures', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525583, 'HP:0011145', 'Symptomatic seizures', 'MP:0003725', 'increased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525584, 'HP:0011145', 'Symptomatic seizures', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525585, 'HP:0011145', 'Symptomatic seizures', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525586, 'HP:0011145', 'Symptomatic seizures', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525587, 'HP:0011145', 'Symptomatic seizures', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525588, 'HP:0011145', 'Symptomatic seizures', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525589, 'HP:0011145', 'Symptomatic seizures', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525590, 'HP:0011145', 'Symptomatic seizures', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525591, 'HP:0011145', 'Symptomatic seizures', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525592, 'HP:0011145', 'Symptomatic seizures', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525593, 'HP:0011145', 'Symptomatic seizures', 'MP:0005088', 'increased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525594, 'HP:0011145', 'Symptomatic seizures', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525595, 'HP:0011145', 'Symptomatic seizures', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525596, 'HP:0011145', 'Symptomatic seizures', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525597, 'HP:0011145', 'Symptomatic seizures', 'MP:0005005', 'abnormal self tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525598, 'HP:0011145', 'Symptomatic seizures', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525599, 'HP:0011145', 'Symptomatic seizures', 'MP:0002207', 'abnormal long-term potentiation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525600, 'HP:0011145', 'Symptomatic seizures', 'MP:0003469', 'decreased single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525601, 'HP:0011145', 'Symptomatic seizures', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525602, 'HP:0011145', 'Symptomatic seizures', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525603, 'HP:0011145', 'Symptomatic seizures', 'MP:0001793', 'abnormal susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525604, 'HP:0011145', 'Symptomatic seizures', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525605, 'HP:0011145', 'Symptomatic seizures', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525606, 'HP:0011145', 'Symptomatic seizures', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525607, 'HP:0011145', 'Symptomatic seizures', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525608, 'HP:0011145', 'Symptomatic seizures', 'MP:0010515', 'abnormal Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525609, 'HP:0011145', 'Symptomatic seizures', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525610, 'HP:0011145', 'Symptomatic seizures', 'MP:0008558', 'abnormal interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525611, 'HP:0011145', 'Symptomatic seizures', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525612, 'HP:0011145', 'Symptomatic seizures', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525613, 'HP:0011145', 'Symptomatic seizures', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525614, 'HP:0011145', 'Symptomatic seizures', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525615, 'HP:0011145', 'Symptomatic seizures', 'MP:0003219', 'increased spike-wave discharge type II', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525616, 'HP:0011145', 'Symptomatic seizures', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525617, 'HP:0011145', 'Symptomatic seizures', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525618, 'HP:0011145', 'Symptomatic seizures', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525619, 'HP:0011145', 'Symptomatic seizures', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525620, 'HP:0011145', 'Symptomatic seizures', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525621, 'HP:0011145', 'Symptomatic seizures', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525622, 'HP:0011145', 'Symptomatic seizures', 'MP:0003633', 'abnormal nervous system physiology', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525623, 'HP:0011145', 'Symptomatic seizures', 'MP:0003216', 'absence seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525624, 'HP:0011145', 'Symptomatic seizures', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525625, 'HP:0011145', 'Symptomatic seizures', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525626, 'HP:0011145', 'Symptomatic seizures', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525627, 'HP:0011145', 'Symptomatic seizures', 'MP:0021013', 'abnormal synaptic vesicle endocytosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525628, 'HP:0011145', 'Symptomatic seizures', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525629, 'HP:0011145', 'Symptomatic seizures', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525630, 'HP:0011145', 'Symptomatic seizures', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525631, 'HP:0011145', 'Symptomatic seizures', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525632, 'HP:0011145', 'Symptomatic seizures', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525633, 'HP:0011145', 'Symptomatic seizures', 'MP:0021001', 'impaired neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525634, 'HP:0011145', 'Symptomatic seizures', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525635, 'HP:0011145', 'Symptomatic seizures', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525636, 'HP:0011145', 'Symptomatic seizures', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525637, 'HP:0011145', 'Symptomatic seizures', 'MP:0011397', 'endoneurial edema', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525638, 'HP:0011145', 'Symptomatic seizures', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525639, 'HP:0011145', 'Symptomatic seizures', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525640, 'HP:0011145', 'Symptomatic seizures', 'MP:0006060', 'increased cerebral infarct size', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525641, 'HP:0011145', 'Symptomatic seizures', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525642, 'HP:0011145', 'Symptomatic seizures', 'MP:0020371', 'abnormal glymphatic system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525643, 'HP:0011145', 'Symptomatic seizures', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525644, 'HP:0011145', 'Symptomatic seizures', 'MP:0030129', 'tongue inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525645, 'HP:0011145', 'Symptomatic seizures', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525646, 'HP:0011145', 'Symptomatic seizures', 'MP:0002406', 'increased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525647, 'HP:0011145', 'Symptomatic seizures', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525648, 'HP:0011145', 'Symptomatic seizures', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525649, 'HP:0011145', 'Symptomatic seizures', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525650, 'HP:0011145', 'Symptomatic seizures', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525651, 'HP:0011145', 'Symptomatic seizures', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525652, 'HP:0011145', 'Symptomatic seizures', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525653, 'HP:0011145', 'Symptomatic seizures', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525654, 'HP:0011145', 'Symptomatic seizures', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525655, 'HP:0011145', 'Symptomatic seizures', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525656, 'HP:0011145', 'Symptomatic seizures', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525657, 'HP:0011145', 'Symptomatic seizures', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525658, 'HP:0011145', 'Symptomatic seizures', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525659, 'HP:0011145', 'Symptomatic seizures', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525660, 'HP:0011145', 'Symptomatic seizures', 'MP:0012503', 'increased midbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525661, 'HP:0011145', 'Symptomatic seizures', 'MP:0001876', 'decreased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525662, 'HP:0011145', 'Symptomatic seizures', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525663, 'HP:0011145', 'Symptomatic seizures', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525664, 'HP:0011145', 'Symptomatic seizures', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525665, 'HP:0011145', 'Symptomatic seizures', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525666, 'HP:0011145', 'Symptomatic seizures', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525667, 'HP:0011145', 'Symptomatic seizures', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525668, 'HP:0011145', 'Symptomatic seizures', 'MP:0008814', 'decreased nerve conduction velocity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525669, 'HP:0011145', 'Symptomatic seizures', 'MP:0005646', 'abnormal pituitary gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525670, 'HP:0011145', 'Symptomatic seizures', 'MP:0001500', 'decreased kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525671, 'HP:0011145', 'Symptomatic seizures', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525672, 'HP:0011145', 'Symptomatic seizures', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525673, 'HP:0011145', 'Symptomatic seizures', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525674, 'HP:0011145', 'Symptomatic seizures', 'MP:0003473', 'decreased summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525675, 'HP:0011145', 'Symptomatic seizures', 'MP:0005087', 'decreased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525676, 'HP:0011145', 'Symptomatic seizures', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525677, 'HP:0011145', 'Symptomatic seizures', 'MP:0002826', 'tonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525678, 'HP:0011145', 'Symptomatic seizures', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525679, 'HP:0011145', 'Symptomatic seizures', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525680, 'HP:0011145', 'Symptomatic seizures', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525681, 'HP:0011145', 'Symptomatic seizures', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525682, 'HP:0011145', 'Symptomatic seizures', 'MP:0010654', 'slow Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525683, 'HP:0011145', 'Symptomatic seizures', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525684, 'HP:0011145', 'Symptomatic seizures', 'MP:0001916', 'intracerebral hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525685, 'HP:0011145', 'Symptomatic seizures', 'MP:0003467', 'abnormal single cell response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525686, 'HP:0011145', 'Symptomatic seizures', 'MP:0002635', 'reduced sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525687, 'HP:0011145', 'Symptomatic seizures', 'MP:0012261', 'increased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525688, 'HP:0011145', 'Symptomatic seizures', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525689, 'HP:0011145', 'Symptomatic seizures', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525690, 'HP:0011145', 'Symptomatic seizures', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525691, 'HP:0011145', 'Symptomatic seizures', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525692, 'HP:0011145', 'Symptomatic seizures', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525693, 'HP:0011145', 'Symptomatic seizures', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525694, 'HP:0011145', 'Symptomatic seizures', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525695, 'HP:0011145', 'Symptomatic seizures', 'MP:0013438', 'dysmyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525696, 'HP:0011145', 'Symptomatic seizures', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525697, 'HP:0011145', 'Symptomatic seizures', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525698, 'HP:0011145', 'Symptomatic seizures', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525699, 'HP:0011145', 'Symptomatic seizures', 'MP:0008840', 'abnormal spike wave discharge', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525700, 'HP:0011145', 'Symptomatic seizures', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525701, 'HP:0011145', 'Symptomatic seizures', 'MP:0001844', 'autoimmune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525702, 'HP:0011145', 'Symptomatic seizures', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525703, 'HP:0011145', 'Symptomatic seizures', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525704, 'HP:0011145', 'Symptomatic seizures', 'MP:0031117', 'subdural hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525705, 'HP:0011145', 'Symptomatic seizures', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525706, 'HP:0011145', 'Symptomatic seizures', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525707, 'HP:0011145', 'Symptomatic seizures', 'MP:0002472', 'impaired complement alternative pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525708, 'HP:0011145', 'Symptomatic seizures', 'MP:0002064', 'seizures', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525709, 'HP:0011145', 'Symptomatic seizures', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525710, 'HP:0011145', 'Symptomatic seizures', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525711, 'HP:0011145', 'Symptomatic seizures', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525712, 'HP:0011145', 'Symptomatic seizures', 'MP:0014120', 'focal seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525713, 'HP:0011145', 'Symptomatic seizures', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525714, 'HP:0011145', 'Symptomatic seizures', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525715, 'HP:0011145', 'Symptomatic seizures', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525716, 'HP:0011145', 'Symptomatic seizures', 'MP:0006058', 'decreased cerebral infarct size', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525717, 'HP:0011145', 'Symptomatic seizures', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525718, 'HP:0011145', 'Symptomatic seizures', 'MP:0020000', 'abnormal response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525719, 'HP:0011145', 'Symptomatic seizures', 'MP:0003202', 'abnormal neuron apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525720, 'HP:0011145', 'Symptomatic seizures', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525721, 'HP:0011145', 'Symptomatic seizures', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525722, 'HP:0011145', 'Symptomatic seizures', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525723, 'HP:0011145', 'Symptomatic seizures', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525724, 'HP:0011145', 'Symptomatic seizures', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525725, 'HP:0011145', 'Symptomatic seizures', 'MP:0000951', 'sporadic seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525726, 'HP:0011145', 'Symptomatic seizures', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525727, 'HP:0011145', 'Symptomatic seizures', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525728, 'HP:0011145', 'Symptomatic seizures', 'MP:0010368', 'abnormal lymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525729, 'HP:0011145', 'Symptomatic seizures', 'MP:0002922', 'decreased post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525730, 'HP:0011145', 'Symptomatic seizures', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525731, 'HP:0011145', 'Symptomatic seizures', 'MP:0004751', 'increased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525732, 'HP:0011145', 'Symptomatic seizures', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525733, 'HP:0011145', 'Symptomatic seizures', 'MP:0009142', 'decreased prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525734, 'HP:0011145', 'Symptomatic seizures', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525735, 'HP:0011145', 'Symptomatic seizures', 'MP:0021083', 'increased cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525736, 'HP:0011145', 'Symptomatic seizures', 'MP:0003466', 'decreased single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525737, 'HP:0011145', 'Symptomatic seizures', 'MP:0004752', 'decreased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525738, 'HP:0011145', 'Symptomatic seizures', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525739, 'HP:0011145', 'Symptomatic seizures', 'MP:0000920', 'abnormal myelination', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525740, 'HP:0011145', 'Symptomatic seizures', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525741, 'HP:0011145', 'Symptomatic seizures', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525742, 'HP:0011145', 'Symptomatic seizures', 'MP:0012553', 'decreased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525743, 'HP:0011145', 'Symptomatic seizures', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525744, 'HP:0011145', 'Symptomatic seizures', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525745, 'HP:0011145', 'Symptomatic seizures', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525746, 'HP:0011145', 'Symptomatic seizures', 'MP:0002419', 'abnormal innate immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525747, 'HP:0011145', 'Symptomatic seizures', 'MP:0003929', 'decreased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525748, 'HP:0011145', 'Symptomatic seizures', 'MP:0012006', 'abnormal hippocampus physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525749, 'HP:0011145', 'Symptomatic seizures', 'MP:0004879', 'decreased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525750, 'HP:0011145', 'Symptomatic seizures', 'MP:0003996', 'clonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525751, 'HP:0011145', 'Symptomatic seizures', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525752, 'HP:0011145', 'Symptomatic seizures', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525753, 'HP:0011145', 'Symptomatic seizures', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525754, 'HP:0011145', 'Symptomatic seizures', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525755, 'HP:0011145', 'Symptomatic seizures', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525756, 'HP:0011145', 'Symptomatic seizures', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525757, 'HP:0011145', 'Symptomatic seizures', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525758, 'HP:0011145', 'Symptomatic seizures', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525759, 'HP:0011145', 'Symptomatic seizures', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525760, 'HP:0011145', 'Symptomatic seizures', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525761, 'HP:0011145', 'Symptomatic seizures', 'MP:0030991', 'optic nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525762, 'HP:0011145', 'Symptomatic seizures', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525763, 'HP:0011145', 'Symptomatic seizures', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525764, 'HP:0011145', 'Symptomatic seizures', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525765, 'HP:0011145', 'Symptomatic seizures', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525766, 'HP:0011145', 'Symptomatic seizures', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525767, 'HP:0011145', 'Symptomatic seizures', 'MP:0003482', 'increased nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525768, 'HP:0011145', 'Symptomatic seizures', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525769, 'HP:0011145', 'Symptomatic seizures', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525770, 'HP:0011145', 'Symptomatic seizures', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525771, 'HP:0011145', 'Symptomatic seizures', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525772, 'HP:0011145', 'Symptomatic seizures', 'MP:0006051', 'brainstem hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525773, 'HP:0011145', 'Symptomatic seizures', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525774, 'HP:0011145', 'Symptomatic seizures', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525775, 'HP:0011145', 'Symptomatic seizures', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525776, 'HP:0011145', 'Symptomatic seizures', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525777, 'HP:0011145', 'Symptomatic seizures', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525778, 'HP:0011145', 'Symptomatic seizures', 'MP:0006054', 'spinal hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525779, 'HP:0011145', 'Symptomatic seizures', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525780, 'HP:0011145', 'Symptomatic seizures', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525781, 'HP:0011145', 'Symptomatic seizures', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525782, 'HP:0034913', 'Acrosomal hypoplasia', 'MP:0020550', 'multinucleated giant male germ cells', 0.4090909090909091, 11.607147267911277, 2.179077425834586, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(525783, 'HP:0034913', 'Acrosomal hypoplasia', 'MP:0005578', 'teratozoospermia', 0.41304347826086957, 11.607147267911277, 2.1895790646204634, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(525784, 'HP:0034913', 'Acrosomal hypoplasia', 'MP:0001124', 'abnormal gametes', 0.4186046511627907, 10.791230332350247, 2.1253844849557932, 'UPHENO:0085194', 'abnormal gamete'),
(525785, 'HP:0034913', 'Acrosomal hypoplasia', 'MP:0006362', 'abnormal male germ cell morphology', 0.4186046511627907, 11.607147267911277, 2.204269909307646, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(525786, 'HP:0034913', 'Acrosomal hypoplasia', 'MP:0002208', 'abnormal germ cell morphology', 0.40476190476190477, 10.700256672302757, 2.0811189951856535, 'UPHENO:0084966', 'abnormal germ cell morphology'),
(525787, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0000734', 'muscle hypoplasia', 0.4222222222222222, 8.202005804774931, 1.8609323248231349, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(525788, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0012483', 'increased corticospinal tract size', 0.41304347826086957, 13.732678149995134, 2.3816366534194575, 'UPHENO:0076726', 'abnormal corticospinal tract morphology'),
(525789, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0012092', 'diencephalon hypoplasia', 0.44, 8.202005804774931, 1.899705912529876, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(525790, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0000851', 'cerebellum hypoplasia', 0.4074074074074074, 8.202005804774931, 1.8279928666337462, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(525791, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0000956', 'decreased spinal cord size', 0.4318181818181818, 5.838687225017717, 1.5878448607191435, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(525792, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0000774', 'decreased brain size', 0.41304347826086957, 5.838687225017717, 1.5529429094138079, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(525793, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0012484', 'decreased corticospinal tract size', 0.5116279069767442, 15.607147267911275, 2.8257834472158794, 'UPHENO:0069359', 'decreased size of the corticospinal tract'),
(525794, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0000071', 'axial skeleton hypoplasia', 0.41304347826086957, 8.202005804774931, 1.8405936559491016, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(525795, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0012264', 'hindbrain hypoplasia', 0.4074074074074074, 8.202005804774931, 1.8279928666337462, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(525796, 'HP:0007016', 'Corticospinal tract hypoplasia', 'MP:0000785', 'telencephalon hypoplasia', 0.44, 8.202005804774931, 1.899705912529876, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(525797, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0004662', 'abnormal thyroid diverticulum morphology', 0.4444444444444444, 11.668547812575419, 2.277283743856597, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525798, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0013235', 'abnormal thyroglossal duct morphology', 0.43243243243243246, 11.668547812575419, 2.2462988477818633, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525799, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0004696', 'abnormal thyroid follicle morphology', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525800, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0013528', 'thyroid gland cyst', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525801, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0003421', 'abnormal thyroid gland development', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525802, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0000681', 'abnormal thyroid gland morphology', 0.48484848484848486, 11.668547812575419, 2.3785452964594334, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525803, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0013937', 'absent lobe of thyroid gland', 0.47058823529411764, 11.668547812575419, 2.3433056402366517, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525804, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0004663', 'athyroidism', 0.47058823529411764, 11.668547812575419, 2.3433056402366517, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525805, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0013560', 'abnormal endocrine gland morphology', 0.4375, 7.914822368502075, 1.8608424936623889, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(525806, 'HP:0011777', 'Thyroid papillary adenoma', 'MP:0013162', 'abnormal thyroid gland isthmus morphology', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(525807, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525808, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002915', 'abnormal synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525809, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525810, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525811, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525812, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003990', 'decreased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525813, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004751', 'increased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525814, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525815, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525816, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002195', 'psychomotor seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525817, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525818, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012006', 'abnormal hippocampus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525819, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525820, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525821, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525822, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525823, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525824, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525825, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525826, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525827, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525828, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009142', 'decreased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525829, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525830, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525831, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014253', 'decreased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525832, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525833, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525834, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525835, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525836, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525837, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525838, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525839, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525840, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525841, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525842, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003469', 'decreased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525843, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525844, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525845, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525846, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525847, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010653', 'abnormal Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525848, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525849, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525850, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008568', 'abnormal interleukin secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525851, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014120', 'focal seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525852, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525853, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525854, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525855, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525856, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525857, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525858, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525859, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525860, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525861, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525862, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012504', 'increased forebrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525863, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525864, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525865, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525866, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525867, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525868, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003465', 'increased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525869, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006053', 'hypothalamus hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525870, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003464', 'abnormal single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525871, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525872, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525873, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525874, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525875, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525876, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525877, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002500', 'granulomatous inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525878, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525879, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525880, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012011', 'febrile seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525881, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525882, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525883, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525884, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525885, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525886, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525887, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021015', 'increased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525888, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525889, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525890, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002635', 'reduced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525891, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003471', 'abnormal summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525892, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525893, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525894, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525895, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525896, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525897, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002923', 'increased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525898, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525899, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525900, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525901, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525902, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525903, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004994', 'abnormal brain wave pattern', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525904, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525905, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525906, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525907, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525908, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003997', 'tonic-clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525909, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525910, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525911, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525912, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002914', 'abnormal endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525913, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005403', 'abnormal nerve conduction', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525914, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525915, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525916, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525917, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525918, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525919, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001800', 'abnormal humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525920, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525921, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525922, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525923, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525924, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525925, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525926, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003088', 'abnormal prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525927, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525928, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525929, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525930, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003880', 'abnormal central pattern generator function', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525931, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525932, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525933, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525934, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525935, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525936, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525937, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003477', 'abnormal nerve fiber response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525938, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525939, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525940, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004859', 'abnormal synaptic plasticity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525941, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525942, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525943, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525944, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003009', 'abnormal cytokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525945, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525946, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525947, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525948, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525949, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525950, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525951, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525952, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525953, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525954, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525955, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525956, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525957, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525958, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525959, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525960, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525961, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525962, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525963, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525964, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001900', 'impaired synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525965, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003474', 'abnormal summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525966, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525967, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003216', 'absence seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525968, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008747', 'abnormal T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525969, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001496', 'audiogenic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525970, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525971, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525972, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525973, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525974, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002917', 'decreased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525975, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525976, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525977, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525978, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021001', 'impaired neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525979, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525980, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525981, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003484', 'abnormal channel response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525982, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525983, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003635', 'abnormal synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525984, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010050', 'hypermyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525985, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525986, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525987, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525988, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525989, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525990, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525991, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525992, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525993, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525994, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525995, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(525996, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525997, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525998, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(525999, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526000, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526001, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526002, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002634', 'abnormal sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526003, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526004, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031109', 'subarachnoid hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526005, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526006, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526007, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526008, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526009, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526010, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526011, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526012, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526013, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526014, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003219', 'increased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526015, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526016, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526017, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003473', 'decreased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526018, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526019, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526020, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526021, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526022, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526023, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526024, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526025, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526026, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526027, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003485', 'abnormal channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526028, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526029, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014255', 'increased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526030, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526031, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001898', 'abnormal long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526032, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526033, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002916', 'increased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526034, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002064', 'seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526035, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020424', 'increased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526036, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526037, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526038, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526039, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526040, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526041, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526042, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526043, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526044, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526045, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526046, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526047, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001473', 'reduced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526048, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526049, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526050, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526051, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526052, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526053, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526054, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526055, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526056, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526057, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526058, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526059, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526060, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003482', 'increased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526061, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526062, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003467', 'abnormal single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526063, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526064, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526065, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526066, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526067, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526068, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526069, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526070, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526071, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526072, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526073, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526074, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526075, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001847', 'brain inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526076, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526077, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526078, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526079, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526080, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526081, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526082, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526083, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526084, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526085, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526086, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526087, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526088, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526089, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526090, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526091, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526092, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526093, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526094, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526095, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526096, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526097, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526098, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526099, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526100, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526101, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526102, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526103, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526104, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526105, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526106, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526107, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526108, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526109, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003468', 'increased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526110, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009967', 'abnormal neuron proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526111, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526112, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526113, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526114, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526115, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526116, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526117, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003463', 'abnormal single cell response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526118, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526119, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003487', 'increased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526120, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526121, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526122, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526123, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526124, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012503', 'increased midbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526125, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008921', 'increased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526126, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526127, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526128, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526129, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526130, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526131, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526132, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526133, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526134, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526135, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526136, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526137, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003008', 'enhanced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526138, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013806', 'encephalopathy', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526139, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526140, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003475', 'increased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526141, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526142, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526143, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526144, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526145, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003202', 'abnormal neuron apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526146, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000951', 'sporadic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526147, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526148, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526149, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526150, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526151, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526152, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526153, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526154, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526155, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001500', 'decreased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526156, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526157, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526158, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000920', 'abnormal myelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526159, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526160, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526161, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526162, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526163, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526164, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526165, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002920', 'decreased paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526166, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526167, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526168, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003480', 'increased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526169, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526170, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526171, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000947', 'convulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526172, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526173, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010149', 'abnormal synaptic dopamine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526174, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526175, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526176, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526177, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526178, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526179, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526180, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002193', 'minimal clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526181, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526182, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526183, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526184, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526185, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526186, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003476', 'decreased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526187, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526188, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526189, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526190, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526191, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526192, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526193, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526194, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526195, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009358', 'environmentally induced seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526196, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526197, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526198, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526199, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011397', 'endoneurial edema', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526200, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526201, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526202, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526203, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526204, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014254', 'increased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526205, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526206, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526207, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526208, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014178', 'increased brain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526209, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526210, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526211, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526212, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526213, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526214, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526215, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001475', 'reduced long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526216, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526217, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526218, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004513', 'avnosmia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526219, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526220, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526221, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526222, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526223, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526224, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006052', 'cerebellum hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526225, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526226, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526227, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004495', 'decreased synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526228, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526229, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526230, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526231, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526232, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526233, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004811', 'abnormal neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526234, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526235, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526236, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526237, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526238, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003470', 'abnormal summary potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526239, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526240, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526241, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526242, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526243, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526244, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526245, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526246, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006060', 'increased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526247, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008814', 'decreased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526248, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526249, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526250, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526251, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526252, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526253, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526254, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526255, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004768', 'abnormal axonal transport', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526256, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526257, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526258, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013438', 'dysmyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526259, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526260, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526261, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526262, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526263, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526264, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003490', 'decreased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526265, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526266, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526267, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526268, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526269, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526270, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526271, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526272, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021010', 'impaired synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526273, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003996', 'clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526274, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526275, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526276, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526277, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526278, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526279, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003633', 'abnormal nervous system physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526280, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526281, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526282, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526283, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526284, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526285, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526286, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526287, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526288, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526289, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526290, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526291, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526292, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003466', 'decreased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526293, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526294, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526295, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526296, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021009', 'abnormal synaptic physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526297, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526298, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526299, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526300, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526301, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526302, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010654', 'slow Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526303, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526304, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526305, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001844', 'autoimmune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526306, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003889', 'enhanced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526307, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526308, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526309, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526310, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526311, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526312, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526313, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003218', 'decreased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526314, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526315, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526316, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526317, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005044', 'sepsis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526318, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526319, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526320, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526321, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526322, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526323, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003488', 'decreased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526324, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526325, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012502', 'decreased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526326, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003489', 'increased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526327, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526328, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003220', 'decreased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526329, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526330, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031117', 'subdural hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526331, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526332, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526333, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526334, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002578', 'impaired ability to fire action potentials', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526335, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000921', 'demyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526336, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526337, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526338, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003472', 'increased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526339, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526340, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526341, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526342, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012565', 'perivasculitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526343, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526344, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526345, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526346, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526347, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526348, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526349, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526350, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014256', 'decreased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526351, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526352, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526353, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526354, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001835', 'abnormal antigen presentation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526355, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526356, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001499', 'abnormal kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526357, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006054', 'spinal hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526358, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008840', 'abnormal spike wave discharge', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526359, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526360, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526361, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005402', 'abnormal action potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526362, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526363, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526364, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526365, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526366, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526367, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002419', 'abnormal innate immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526368, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526369, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526370, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526371, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526372, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526373, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526374, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526375, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002207', 'abnormal long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526376, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526377, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526378, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526379, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526380, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526381, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003486', 'abnormal channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526382, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526383, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526384, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526385, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526386, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526387, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526388, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526389, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526390, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526391, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526392, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012261', 'increased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526393, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526394, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000948', 'nonconvulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526395, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526396, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006080', 'brain ischemia', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526397, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526398, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526399, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526400, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526401, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002826', 'tonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526402, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0006058', 'decreased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526403, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526404, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030129', 'tongue inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526405, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004835', 'abnormal miniature endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526406, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526407, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526408, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003217', 'increased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526409, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011994', 'increased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526410, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526411, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526412, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526413, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526414, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526415, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526416, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526417, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526418, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526419, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526420, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526421, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526422, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526423, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526424, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526425, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526426, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526427, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526428, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526429, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0013182', 'increased spinal cord apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526430, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526431, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526432, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526433, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526434, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526435, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526436, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0004494', 'abnormal synaptic glutamate release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526437, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526438, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526439, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526440, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0031110', 'meningitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526441, 'HP:0034893', 'Elevated brain glycine level by MRS', 'MP:0009141', 'increased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526442, 'HP:0003198', 'Myopathy', 'MP:0003119', 'abnormal digestive system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526443, 'HP:0003198', 'Myopathy', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526444, 'HP:0003198', 'Myopathy', 'MP:0003199', 'calcified muscle', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526445, 'HP:0003198', 'Myopathy', 'MP:0002210', 'abnormal sex determination', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526446, 'HP:0003198', 'Myopathy', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526447, 'HP:0003198', 'Myopathy', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526448, 'HP:0003198', 'Myopathy', 'MP:0013332', 'peliosis', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526449, 'HP:0003198', 'Myopathy', 'MP:0013126', 'teat swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526450, 'HP:0003198', 'Myopathy', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526451, 'HP:0003198', 'Myopathy', 'MP:0006279', 'abnormal limb development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526452, 'HP:0003198', 'Myopathy', 'MP:0000736', 'delayed muscle development', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526453, 'HP:0003198', 'Myopathy', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526454, 'HP:0003198', 'Myopathy', 'MP:0009407', 'increased skeletal muscle fiber density', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526455, 'HP:0003198', 'Myopathy', 'MP:0010352', 'gastrointestinal tract polyps', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526456, 'HP:0003198', 'Myopathy', 'MP:0020973', 'abnormal gland development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526457, 'HP:0003198', 'Myopathy', 'MP:0002925', 'abnormal cardiovascular development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526458, 'HP:0003198', 'Myopathy', 'MP:0001726', 'abnormal allantois morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526459, 'HP:0003198', 'Myopathy', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526460, 'HP:0003198', 'Myopathy', 'MP:0003936', 'abnormal reproductive system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526461, 'HP:0003198', 'Myopathy', 'MP:0003385', 'abnormal body wall morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526462, 'HP:0003198', 'Myopathy', 'MP:0003632', 'abnormal nervous system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526463, 'HP:0003198', 'Myopathy', 'MP:0004818', 'increased skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526464, 'HP:0003198', 'Myopathy', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526465, 'HP:0003198', 'Myopathy', 'MP:0013283', 'failure of ventral body wall closure', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526466, 'HP:0003198', 'Myopathy', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526467, 'HP:0003198', 'Myopathy', 'MP:0013124', 'mouth swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526468, 'HP:0003198', 'Myopathy', 'MP:0003300', 'gastrointestinal ulcer', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526469, 'HP:0003198', 'Myopathy', 'MP:0009419', 'skeletal muscle fibrosis', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526470, 'HP:0003198', 'Myopathy', 'MP:0000462', 'abnormal digestive system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526471, 'HP:0003198', 'Myopathy', 'MP:0002111', 'abnormal tail morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526472, 'HP:0003198', 'Myopathy', 'MP:0031112', 'rhabdomyolysis', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526473, 'HP:0003198', 'Myopathy', 'MP:0010290', 'increased muscle tumor incidence', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526474, 'HP:0003198', 'Myopathy', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526475, 'HP:0003198', 'Myopathy', 'MP:0004819', 'decreased skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526476, 'HP:0003198', 'Myopathy', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526477, 'HP:0003198', 'Myopathy', 'MP:0031277', 'pectus carinatum', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526478, 'HP:0003198', 'Myopathy', 'MP:0010233', 'hairless tail', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526479, 'HP:0003198', 'Myopathy', 'MP:0012249', 'absent myotome', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526480, 'HP:0003198', 'Myopathy', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526481, 'HP:0003198', 'Myopathy', 'MP:0013120', 'urogenital swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526482, 'HP:0003198', 'Myopathy', 'MP:0004134', 'abnormal chest morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526483, 'HP:0003198', 'Myopathy', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526484, 'HP:0003198', 'Myopathy', 'MP:0000731', 'increased collagen deposition in the muscles', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526485, 'HP:0003198', 'Myopathy', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526486, 'HP:0003198', 'Myopathy', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526487, 'HP:0003198', 'Myopathy', 'MP:0008923', 'thoracoschisis', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526488, 'HP:0003198', 'Myopathy', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526489, 'HP:0003198', 'Myopathy', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526490, 'HP:0003198', 'Myopathy', 'MP:0003935', 'abnormal craniofacial development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526491, 'HP:0003198', 'Myopathy', 'MP:0005360', 'urolithiasis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526492, 'HP:0003198', 'Myopathy', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526493, 'HP:0003198', 'Myopathy', 'MP:0010630', 'abnormal cardiac muscle tissue morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526494, 'HP:0003198', 'Myopathy', 'MP:0010478', 'intracranial aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526495, 'HP:0003198', 'Myopathy', 'MP:0013118', 'swellings', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526496, 'HP:0003198', 'Myopathy', 'MP:0003115', 'abnormal respiratory system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526497, 'HP:0003198', 'Myopathy', 'MP:0030222', 'hyperostosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526498, 'HP:0003198', 'Myopathy', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526499, 'HP:0003198', 'Myopathy', 'MP:0003861', 'abnormal nervous system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526500, 'HP:0003198', 'Myopathy', 'MP:0013125', 'thorax swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526501, 'HP:0003198', 'Myopathy', 'MP:0000685', 'abnormal immune system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526502, 'HP:0003198', 'Myopathy', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526503, 'HP:0003198', 'Myopathy', 'MP:0014062', 'nervous system inclusion bodies', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526504, 'HP:0003198', 'Myopathy', 'MP:0002132', 'abnormal respiratory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526505, 'HP:0003198', 'Myopathy', 'MP:0020981', 'abnormal immune system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526506, 'HP:0003198', 'Myopathy', 'MP:0020982', 'abnormal skin adnexa development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526507, 'HP:0003198', 'Myopathy', 'MP:0000733', 'abnormal muscle development', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526508, 'HP:0003198', 'Myopathy', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526509, 'HP:0003198', 'Myopathy', 'MP:0012413', 'decreased muscle tumor incidence', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526510, 'HP:0003198', 'Myopathy', 'MP:0000749', 'muscle degeneration', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526511, 'HP:0003198', 'Myopathy', 'MP:0031377', 'ambiguous external genitalia', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526512, 'HP:0003198', 'Myopathy', 'MP:0003795', 'abnormal bone structure', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526513, 'HP:0003198', 'Myopathy', 'MP:0031310', 'abnormal cyst', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526514, 'HP:0003198', 'Myopathy', 'MP:0013122', 'tail swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526515, 'HP:0003198', 'Myopathy', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526516, 'HP:0003198', 'Myopathy', 'MP:0000767', 'abnormal smooth muscle morphology', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526517, 'HP:0003198', 'Myopathy', 'MP:0013123', 'head/neck swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526518, 'HP:0003198', 'Myopathy', 'MP:0011174', 'lipodystrophy', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526519, 'HP:0003198', 'Myopathy', 'MP:0002160', 'abnormal reproductive system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526520, 'HP:0003198', 'Myopathy', 'MP:0003942', 'abnormal urinary system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526521, 'HP:0003198', 'Myopathy', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526522, 'HP:0003198', 'Myopathy', 'MP:0002836', 'abnormal chorion morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526523, 'HP:0003198', 'Myopathy', 'MP:0013113', 'greasy tail', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526524, 'HP:0003198', 'Myopathy', 'MP:0013177', 'abnormal tail tip morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526525, 'HP:0003198', 'Myopathy', 'MP:0003384', 'abnormal ventral body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526526, 'HP:0003198', 'Myopathy', 'MP:0013119', 'abdomen swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526527, 'HP:0003198', 'Myopathy', 'MP:0003346', 'abnormal pectoral muscle morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526528, 'HP:0003198', 'Myopathy', 'MP:0005499', 'abnormal olfactory system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526529, 'HP:0003198', 'Myopathy', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526530, 'HP:0003198', 'Myopathy', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526531, 'HP:0003198', 'Myopathy', 'MP:0005500', 'abnormal gustatory system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526532, 'HP:0003198', 'Myopathy', 'MP:0004233', 'abnormal muscle weight', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526533, 'HP:0003198', 'Myopathy', 'MP:0012514', 'pectus excavatum', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526534, 'HP:0003198', 'Myopathy', 'MP:0006281', 'abnormal tail development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526535, 'HP:0003198', 'Myopathy', 'MP:0013133', 'pale limbs', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526536, 'HP:0003198', 'Myopathy', 'MP:0000266', 'abnormal heart morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526537, 'HP:0003198', 'Myopathy', 'MP:0003397', 'increased muscle weight', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526538, 'HP:0003198', 'Myopathy', 'MP:0000752', 'dystrophic muscle', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526539, 'HP:0003198', 'Myopathy', 'MP:0014134', 'abnormal embryo morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526540, 'HP:0003198', 'Myopathy', 'MP:0002108', 'abnormal muscle morphology', 0.5714285714285714, 7.206267831629091, 2.029252900049543, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526541, 'HP:0003198', 'Myopathy', 'MP:0002109', 'abnormal limb morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526542, 'HP:0003198', 'Myopathy', 'MP:0002163', 'abnormal gland morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526543, 'HP:0003198', 'Myopathy', 'MP:0011167', 'abnormal adipose tissue development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526544, 'HP:0003198', 'Myopathy', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526545, 'HP:0003198', 'Myopathy', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526546, 'HP:0003198', 'Myopathy', 'MP:0005029', 'abnormal amnion morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526547, 'HP:0003198', 'Myopathy', 'MP:0004817', 'abnormal skeletal muscle mass', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526548, 'HP:0003198', 'Myopathy', 'MP:0003939', 'abnormal myotome morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526549, 'HP:0003198', 'Myopathy', 'MP:0000003', 'abnormal adipose tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526550, 'HP:0003198', 'Myopathy', 'MP:0013121', 'testicular swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526551, 'HP:0003198', 'Myopathy', 'MP:0012260', 'encephalomeningocele', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526552, 'HP:0003198', 'Myopathy', 'MP:0005503', 'abnormal tendon morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526553, 'HP:0003198', 'Myopathy', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526554, 'HP:0003198', 'Myopathy', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526555, 'HP:0003198', 'Myopathy', 'MP:0000428', 'abnormal craniofacial morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526556, 'HP:0003198', 'Myopathy', 'MP:0005508', 'abnormal skeleton morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526557, 'HP:0003198', 'Myopathy', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526558, 'HP:0003198', 'Myopathy', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526559, 'HP:0003198', 'Myopathy', 'MP:0014068', 'abnormal muscle glycogen level', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526560, 'HP:0003198', 'Myopathy', 'MP:0001929', 'abnormal gametogenesis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526561, 'HP:0003198', 'Myopathy', 'MP:0002113', 'abnormal skeleton development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526562, 'HP:0003198', 'Myopathy', 'MP:0003279', 'aneurysm', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526563, 'HP:0003198', 'Myopathy', 'MP:0004087', 'abnormal muscle fiber morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(526564, 'HP:0003198', 'Myopathy', 'MP:0031099', 'abnormal sputum morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(526565, 'HP:0040091', 'Asymmetry of the size of ears', 'MP:0003735', 'cup-shaped ears', 0.43859649122807015, 11.115294171581601, 2.20796943425934, 'UPHENO:0005986', 'abnormal shape of external ear'),
(526566, 'HP:0040091', 'Asymmetry of the size of ears', 'MP:0003715', 'posteriorly rotated ears', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(526567, 'HP:0040091', 'Asymmetry of the size of ears', 'MP:0003736', 'folded helix', 0.4032258064516129, 11.115294171581601, 2.117067182751389, 'UPHENO:0005986', 'abnormal shape of external ear'),
(526568, 'HP:0040091', 'Asymmetry of the size of ears', 'MP:0000022', 'abnormal ear shape', 0.49019607843137253, 11.115294171581601, 2.3342394079272144, 'UPHENO:0005986', 'abnormal shape of external ear'),
(526569, 'HP:0040091', 'Asymmetry of the size of ears', 'MP:0003713', 'abnormal ear rotation', 0.43636363636363634, 10.255471829629862, 2.115446756645537, 'UPHENO:0086699', 'abnormal external ear morphology'),
(526570, 'HP:0040091', 'Asymmetry of the size of ears', 'MP:0003716', 'anteriorly rotated ears', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(526571, 'HP:0040091', 'Asymmetry of the size of ears', 'MP:0000023', 'abnormal ear position', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(526572, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0000523', 'cortical renal glomerulopathies', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526573, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011293', 'dilated nephron', 0.40816326530612246, 8.69825431939161, 1.8842260706894922, 'UPHENO:0076756', 'abnormal nephron morphology'),
(526574, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011859', 'decreased renal glomerulus basement membrane thickness', 0.40350877192982454, 9.804092483287297, 1.9889789636438293, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526575, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0002706', 'abnormal kidney size', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(526576, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0020519', 'renal glomerular immunoglobulin deposits', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526577, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0005264', 'glomerulosclerosis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526578, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0003985', 'renal fibrosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(526579, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011483', 'renal glomerular synechia', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526580, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.4222222222222222, 9.692263881549227, 2.022940729342285, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(526581, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526582, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0021201', 'increased susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526583, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0020518', 'renal glomerular protein deposits', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526584, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.4423076923076923, 9.804092483287297, 2.082408586578051, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526585, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011377', 'renal glomerulus fibrosis', 0.45098039215686275, 9.804092483287297, 2.102725249017345, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526586, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011294', 'renal glomerulus hypertrophy', 0.42592592592592593, 9.804092483287297, 2.0434816291827906, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526587, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011348', 'abnormal renal glomerulus basement membrane morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526588, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0021200', 'decreased susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526589, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.43478260869565216, 9.804092483287297, 2.0646183438536734, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526590, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0003197', 'nephrocalcinosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(526591, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526592, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.40425531914893614, 9.692263881549227, 1.9794315418097665, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(526593, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0003670', 'dilated renal glomerular capsule', 0.41509433962264153, 9.692263881549227, 2.005792580343256, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(526594, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011506', 'glomerular crescent', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526595, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011567', 'increased renal glomerulus lobularity', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526596, 'HP:0025364', 'Glomerular extracapillary hypercellularity', 'MP:0011561', 'renal glomerulus lipidosis', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(526597, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0013497', 'trachea occlusion', 0.4523809523809524, 12.732678149995134, 2.400004389132433, 'UPHENO:0021304', 'abnormal trachea morphology'),
(526598, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002311', 'abnormal inspiratory capacity', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526599, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002313', 'abnormal tidal volume', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526600, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0004549', 'small trachea', 0.4418604651162791, 12.732678149995134, 2.3719331966842434, 'UPHENO:0021304', 'abnormal trachea morphology'),
(526601, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002133', 'abnormal respiratory system physiology', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526602, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0013499', 'trachea fibrosis', 0.4634146341463415, 12.732678149995134, 2.429096413603855, 'UPHENO:0021304', 'abnormal trachea morphology'),
(526603, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002306', 'abnormal functional residual capacity', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526604, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002309', 'abnormal vital capacity', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526605, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002337', 'abnormal whole-body plethysmography', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526606, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002308', 'abnormal residual volume', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526607, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.4090909090909091, 8.526773851447254, 1.8676792193792675, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526608, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0001942', 'abnormal lung volume', 0.4186046511627907, 8.526773851447254, 1.8892716039863309, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(526609, 'HP:0004468', 'Anomalous tracheal cartilage', 'MP:0012672', 'enlarged trachea', 0.4418604651162791, 12.732678149995134, 2.3719331966842434, 'UPHENO:0021304', 'abnormal trachea morphology'),
(526610, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526611, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526612, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.46808510638297873, 9.555485148088783, 2.114894863127742, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526613, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526614, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526615, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526616, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(526617, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526618, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012622', 'increased circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526619, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526620, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526621, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(526622, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.46808510638297873, 9.555485148088783, 2.114894863127742, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526623, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526624, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526625, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526626, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526627, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020985', 'increased circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526628, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526629, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526630, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526631, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526632, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012621', 'decreased circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526633, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008588', 'abnormal circulating interleukin level', 0.41509433962264153, 9.555485148088783, 1.9915892642108393, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526634, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526635, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526636, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010091', 'decreased circulating creatine kinase level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526637, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526638, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526639, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526640, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0013256', 'increased circulating thrombin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526641, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526642, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031076', 'decreased circulating troponin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526643, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.4782608695652174, 9.555485148088783, 2.1377592558663996, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526644, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526645, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526646, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526647, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526648, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011886', 'increased circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526649, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011887', 'decreased circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526650, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526651, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526652, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526653, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526654, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526655, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526656, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526657, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526658, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526659, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526660, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4888888888888889, 9.555485148088783, 2.1613816222137645, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526661, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4583333333333333, 9.555485148088783, 2.09274875690817, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526662, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526663, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(526664, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0009699', 'hyperchylomicronemia', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(526665, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526666, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031079', 'increased circulating troponin I level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526667, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008548', 'abnormal circulating interferon level', 0.41509433962264153, 9.555485148088783, 1.9915892642108393, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526668, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020216', 'decreased circulating complement protein level', 0.41509433962264153, 9.555485148088783, 1.9915892642108393, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526669, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008806', 'increased circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526670, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4583333333333333, 9.555485148088783, 2.09274875690817, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526671, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(526672, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008616', 'abnormal circulating interleukin-12 level', 0.4074074074074074, 9.555485148088783, 1.9730624497726466, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526673, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(526674, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526675, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012618', 'decreased circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526676, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011890', 'increased circulating ferritin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526677, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4888888888888889, 9.555485148088783, 2.1613816222137645, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526678, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010209', 'abnormal circulating chemokine level', 0.41509433962264153, 9.555485148088783, 1.9915892642108393, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526679, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526680, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(526681, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(526682, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.4782608695652174, 9.555485148088783, 2.1377592558663996, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526683, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005416', 'abnormal circulating protein level', 0.55, 9.555485148088783, 2.2924914026990004, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526684, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526685, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005567', 'decreased circulating total protein level', 0.4489795918367347, 9.555485148088783, 2.0712840996808914, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526686, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031243', 'abnormal circulating CSF3 level', 0.41509433962264153, 9.555485148088783, 1.9915892642108393, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526687, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526688, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4888888888888889, 9.555485148088783, 2.1613816222137645, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526689, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526690, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.46808510638297873, 9.555485148088783, 2.114894863127742, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526691, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526692, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526693, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526694, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008805', 'decreased circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526695, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526696, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526697, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(526698, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526699, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526700, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031077', 'increased circulating troponin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526701, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526702, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020248', 'decreased circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526703, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4583333333333333, 9.555485148088783, 2.09274875690817, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526704, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526705, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008619', 'abnormal circulating interleukin-23 level', 0.4074074074074074, 9.555485148088783, 1.9730624497726466, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526706, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.4782608695652174, 9.555485148088783, 2.1377592558663996, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526707, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526708, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526709, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526710, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526711, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526712, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526713, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526714, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020257', 'increased circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526715, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012616', 'increased circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526716, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526717, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526718, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4583333333333333, 9.555485148088783, 2.09274875690817, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526719, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526720, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526721, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(526722, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011893', 'increased circulating transferrin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526723, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526724, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012331', 'increased circulating fibrinogen level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526725, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526726, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010090', 'increased circulating creatine kinase level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526727, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526728, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526729, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031078', 'increased circulating troponin T level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526730, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526731, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.4230769230769231, 9.555485148088783, 2.0106479689295784, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526732, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020217', 'increased circulating complement protein level', 0.41509433962264153, 9.555485148088783, 1.9915892642108393, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526733, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0003349', 'abnormal circulating renin level', 0.46808510638297873, 9.555485148088783, 2.114894863127742, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526734, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0005419', 'decreased circulating serum albumin level', 0.4782608695652174, 9.555485148088783, 2.1377592558663996, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526735, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526736, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526737, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526738, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526739, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526740, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526741, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4583333333333333, 9.555485148088783, 2.09274875690817, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526742, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526743, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.46808510638297873, 9.555485148088783, 2.114894863127742, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526744, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011891', 'decreased circulating ferritin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526745, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(526746, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5365853658536586, 9.555485148088783, 2.264361608510536, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526747, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4583333333333333, 9.555485148088783, 2.09274875690817, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526748, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(526749, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.5116279069767442, 9.555485148088783, 2.2110750476779453, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526750, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0008549', 'abnormal circulating interferon-alpha level', 0.4074074074074074, 9.555485148088783, 1.9730624497726466, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526751, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020247', 'increased circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526752, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526753, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526754, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0012619', 'increased circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526755, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.5238095238095238, 9.555485148088783, 2.2372425271278398, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526756, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526757, 'HP:0410176', 'Abnormal circulating glucose-6-phosphate dehydrogenase concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.43137254901960786, 9.555485148088783, 2.030264511202928, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(526758, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526759, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526760, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526761, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526762, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000921', 'demyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526763, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526764, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526765, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526766, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526767, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526768, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526769, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526770, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526771, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526772, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526773, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526774, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020424', 'increased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526775, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526776, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526777, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009142', 'decreased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526778, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526779, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526780, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526781, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011397', 'endoneurial edema', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526782, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526783, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526784, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526785, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526786, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526787, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526788, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526789, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526790, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526791, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006060', 'increased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526792, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526793, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526794, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003472', 'increased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526795, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526796, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526797, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526798, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526799, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526800, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526801, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526802, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526803, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0013438', 'dysmyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526804, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526805, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526806, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526807, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526808, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526809, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526810, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526811, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526812, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005403', 'abnormal nerve conduction', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526813, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526814, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526815, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004768', 'abnormal axonal transport', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526816, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526817, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526818, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526819, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526820, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526821, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526822, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526823, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526824, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001473', 'reduced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526825, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526826, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526827, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526828, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526829, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526830, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526831, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526832, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526833, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526834, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526835, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526836, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526837, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003475', 'increased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526838, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009141', 'increased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526839, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526840, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526841, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526842, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526843, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003488', 'decreased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526844, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526845, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526846, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000948', 'nonconvulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526847, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526848, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526849, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526850, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526851, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526852, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526853, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526854, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000951', 'sporadic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526855, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526856, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526857, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526858, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526859, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526860, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526861, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002064', 'seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526862, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526863, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526864, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526865, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526866, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526867, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526868, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526869, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526870, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006080', 'brain ischemia', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526871, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526872, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526873, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526874, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526875, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000947', 'convulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526876, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005402', 'abnormal action potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526877, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526878, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526879, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526880, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526881, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526882, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526883, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526884, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003470', 'abnormal summary potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526885, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009358', 'environmentally induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526886, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526887, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526888, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526889, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526890, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526891, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526892, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003466', 'decreased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526893, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526894, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526895, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003486', 'abnormal channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526896, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526897, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526898, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526899, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003468', 'increased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526900, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526901, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526902, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526903, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526904, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012011', 'febrile seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526905, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526906, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526907, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003469', 'decreased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526908, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526909, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526910, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003476', 'decreased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526911, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002915', 'abnormal synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526912, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526913, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526914, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526915, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526916, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526917, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526918, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001499', 'abnormal kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526919, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526920, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526921, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526922, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526923, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526924, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526925, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526926, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526927, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003485', 'abnormal channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526928, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002914', 'abnormal endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526929, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526930, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526931, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526932, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526933, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526934, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003997', 'tonic-clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526935, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526936, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001898', 'abnormal long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526937, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526938, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003996', 'clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526939, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003484', 'abnormal channel response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526940, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526941, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526942, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526943, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009967', 'abnormal neuron proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526944, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003489', 'increased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526945, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001500', 'decreased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526946, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526947, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526948, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526949, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526950, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526951, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526952, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526953, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002826', 'tonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526954, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526955, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526956, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526957, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526958, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526959, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526960, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526961, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526962, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526963, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526964, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526965, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526966, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526967, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526968, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526969, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002193', 'minimal clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526970, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526971, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0013806', 'encephalopathy', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526972, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526973, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526974, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526975, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004513', 'avnosmia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526976, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526977, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526978, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526979, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526980, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526981, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003216', 'absence seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526982, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526983, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526984, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526985, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526986, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526987, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526988, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526989, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526990, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526991, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526992, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526993, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526994, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526995, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526996, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526997, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(526998, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003487', 'increased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(526999, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001496', 'audiogenic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527000, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527001, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527002, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(527003, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004811', 'abnormal neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527004, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(527005, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003465', 'increased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527006, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527007, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0021010', 'impaired synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527008, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527009, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(527010, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527011, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002916', 'increased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527012, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(527013, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0003008', 'enhanced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527014, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527015, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(527016, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527017, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(527018, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(527019, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(527020, 'HP:0011174', 'Focal hyperkinetic seizure', 'MP:0002917', 'decreased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
